drugset / Trial / NCT07020949

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM

NCT07020949 ↗

Phase 1 Completed 49 enrolled Tonghua Dongbao Pharmaceutical Co.,Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with T2DM. This study includes three multiple-ascending dose cohorts.

Timeline

Start
2024-06-13
Primary completion
2024-11-27
Completion
2024-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject THDBH120 Unknown — Subcutaneous